Advertising

Research
Volume 54, Issue 6, June 2025

Impact of family physician–led hospitalist intervention methods in the multidisciplinary management of hip fracture: A retrospective cohort study

Naoto Ishimaru    Takahiro Waki    Toshio Shimokawa    Shimpei Mizuki    Yohei Kanzawa    Takahiro Nakajima    Kenjiro Ito    Saori Kinami   
doi: 10.31128/AJGP-03-24-7215   |    Download article
Cite this article    BIBTEX    REFER    RIS

Background and objectives
Hip fractures are associated with high morbidity and mortality. We compared the impacts of a hospitalist consultant model and hospitalist model on morbidity in patients with hip fractures with conventional orthopaedic surgeon–led care.
Methods
This retrospective cohort study included patients who underwent surgery for hip fractures between April 2017 and March 2022. The primary outcome was the rate of perioperative complications. Multivariate analysis was adjusted for age, gender and any significant variables shown in univariate analysis.
Results
Of the 982 patients, 329, 224 and 429 were treated within the orthopaedic department, the hospitalist consultant model and the hospitalist model, respectively. In adjusted analysis, time to surgery was shorter within the hospitalist model (odds ratio [OR]: –0.259; 95% confidence interval [CI]: –0.502 to –0.016), but there were no differences among groups in length of stay, complications or in-hospital mortality.
Discussion
A family physician–led hospitalist model might facilitate earlier surgery for hip fractures than a conventional care model.
 

Hip fractures are associated with high mortality and morbidity,1,2 the rates of which can be lowered by comprehensive hospital care.1,2 Geriatricians can play a major role in the comprehensive care of patients with hip fractures, although specialised geriatricians are limited in number. Hospitalists might therefore assume a useful role in interdisciplinary care; they can respond to consultations for preoperative medical evaluation and the management of postoperative complications, or they can be responsible for the entirety of patient care with an admission of the patient to the Department of General Internal Medicine.

In hospitalist consultant models, a hospitalist works with an orthopaedist during perioperative medical evaluation and management. As the name implies, hospitalists serve as consultants with consideration of the overall care of hospitalised patients. The hospitalist consultant model has been shown to decrease time to surgery and length of stay compared with conventional orthopaedic treatment.3,4 Meanwhile, in the hospitalist model, the hospitalist team leads the management of perioperative and postacute care. Hospitalist models have also been shown to decrease time to surgery and length of stay compared with conventional orthopaedic treatment, as well as reducing time from surgery to dismissal and postoperative complications.5–8

In Japan, some studies have evaluated the effect of the co-management model. A retrospective cohort study of a multidisciplinary model with internists and a geriatrician showed a shorter time to surgery and hospital stay than the national average.9 Another retrospective cohort study of a hospitalist co-management model showed shorter times to surgery than conventional orthopaedic surgeon–led care.10 The clinical effects of the different hospitalist intervention methods have not yet been sufficiently investigated. Therefore, this study examined the effect of these two hospitalist intervention methods (hospitalist model and hospitalist consultant model) on morbidity in patients with hip fractures compared with conventional orthopaedic surgeon–led care.

Methods

Study design

We conducted a retrospective cohort study at Akashi Medical Centre (Hyogo, Japan), a community medical support centre in Japan that includes an emergency medical care centre and primary care practice. Patients who underwent surgery for hip fractures between April 2017 and March 2022 were included in this study, whereas patients with periprosthetic fractures were excluded owing to differences in treatment and patient burden.

The study period comprised two years of a conventional orthopaedic model (OM; between April 2017 and March 2019), then a hospitalist consultant model for one year (HCM; between April 2019 and March 2020), followed by two years of a family physician–led hospitalist model (HM; between April 2020 and March 2022). In the OM, patients were admitted to the orthopaedics department and the medical team, including hospitalists, did not actively manage medical conditions unless asked, so there might be an issue with medical problems not being recognised early. Unnecessary delays in surgery can result in an increased risk of patient, family and staff dissatisfaction.11 In the HCM, patients were admitted to the orthopaedics department and there was a consultation with the hospitalist team, so, theoretically, medical issues would be found earlier than in the OM. However, delays or errors might occur because of a lack of active coordination. The HM can be said to be a more developed, true co-management within a multidisciplinary team. In the present study, we compared the clinical outcomes between each hospitalist group (HCM and HM) and the OM group as a reference group. Throughout the study period, the hospitalist team included two board-certified family physicians who followed the key recommendations for family physicians: perioperative antibiotic prophylaxis, venous thromboembolism (prophylaxis and early rehabilitation and blood transfusion with a haemoglobin threshold of 8 g/dL).12,13

The multidisciplinary team in the HM comprised hospitalists, orthopaedic trauma surgeons, anaesthesiologists, nurses, physiotherapists, ward pharmacists, medical social workers, radiological technologists, ambulatory services and administrative staff. The hospitalist component included three doctors, one resident and one nurse practitioner, and they were responsible for making decisions on admission and when to perform surgery in conjunction with orthopaedists and anaesthesiologists. For patients with hip fractures, orthopaedic surgeons followed a clinical pathway that included directives regarding surgery. Hospitalists performed pre- and post-operative evaluations, as well as medication reconciliation and de-prescribing intervention within a multidisciplinary team.14 In the event of a nurse calling for assistance, hospitalists were to respond first and manage any complications. A weekly conference of hospitalists and orthopaedic surgeons was held with the goal of resolving any concerns or issues about the design or operation of the co-management of patients with hip fractures.

Hip fracture template

We designed and implemented the hip fracture template (HFT), a computerised flagging and risk stratification algorithm system.15 The HFT was created in compliance with the Critical Appraisal Checklist for a Questionnaire Study and reflected the views of users.16 The HFT includes consideration of perioperative management and preventative measures against hip fractures based on previous literature and guidelines (Figure 1).17–20 The HFT includes items such as falls risk assessment, preoperative assessment, management of complications and prevention of refracture. For example, if the user indicates on the interface that the patient is aged ≥65 years, the ‘Order BNP’ (B-type natriuretic peptide) icon will be checked automatically. Similarly, if the BNP value is input as ≥92 pg/mL, the box to suggest daily measurement of troponin would be automatically checked. The HFT became part of the clinical pathway after being piloted in practice.


AJGP-06-2025-RE-Ishimaru-Fig-1.jpg
Figure 1. The hip fracture template is a computerised flagging and risk stratification algorithm system15 that includes items such as fall risk assessment, preoperative assessment, management of complications and prevention of refracture.

BMD, bone mineral density; BNP, B-type natriuretic peptide; BP, blood pressure; CKD, chronic kidney disease; CV, cardiovascular; CVD, cardiovascular disease; DAPT, dual antiplatelet therapy; ECG, electrocardiogram; IHD, ischaemic heart disease; IP, inorganic phosphorus; METS, metabolic equivalents; MI, myocardial infarction; NSAIDs, non-steroidal anti-inflammatory drugs; PTH, parathyroid hormone; RCRI, revised cardiac risk index; VTE, venous thromboembolism.


Outcome measures

We retrospectively obtained data on the presence of complications, along with demographic data, type of fracture, months of the year and American Society of Anesthesiologists physical status (ASA-PS) using medical records from initial hospital visits. Data on months of the year were collected because of a seasonal variation of climate variables on hip fractures with a higher risk of hip fractures in cold seasons.21,22 The primary outcome was the rate of perioperative complications. Secondary outcomes were the time to surgery, length of stay and in-hospital mortality.

Statistical analyses

Univariate analysis was used to identify factors associated with perioperative complications. Fisher’s exact test and Student’s t-test were used for categorical and continuous variables, respectively. Multiple logistic regression analysis was used to identify factors associated with the perioperative complication rate.

The perioperative complication rate was the dependent variable. Covariates were types of fracture, months of the year, age, gender, ASA-PS and any variables that were significant in the univariate analysis. We selected covariates with P<0.2 in univariate analysis for the multivariate regression model. All statistical analyses were performed using R 4.3.0 software (R Foundation for Statistical Computing, Vienna, Austria).

Ethics approval

The study was approved by the Akashi Medical Centre Research Ethics Committee (Approval no. 2022-11). Informed consent was obtained in the form of opt-out on the hospital’s website. All procedures were performed in accordance with the 1964 Declaration of Helsinki.

Results

Among 984 patients, 982 had data that could be analysed; the other two patients were excluded. Altogether, 329 patients were managed in the OM, 224 patients within the HCM and 429 patients within the HM (Figure 2). Baseline demographics and clinical characteristics, including in-hospital mortality and length of stay, are presented in Table 1. The characteristics of the HCM and HM groups at baseline were similar. There were more patients with hip fractures in the HM than in OM group. More patients were ASA-PS 3 and 4 in the HM than HCM group (54.1% vs 46.4%). In-hospital mortality and the rate of complications were similar between the two groups.


AJGP-06-2025-RE-Ishimaru-Fig-2.jpg
Figure 2. Flow chart showing participant disposition.

HCM, hospitalist consultant model; HM, hospitalist model; OM, conventional orthopaedic surgeon-led care.


Table 1. Characteristics of study subjects
  All (n=982) OM (n=329) HCM (n=224) HM (n=429)
Age (years) 83.8±9.5 82.2±9.6 82.8±10.4 83.9±8.8
Female sex 729 (74.2) 246 (74.8) 175 (78.1) 308 (71.8)
Fracture type, femoral neck 557 (56.7) 185 (56.2) 118 (52.7) 154 (35.9)
ASA-PS
 I+II 503 (51.2) 186 (56.5) 120 (53.6) 197 (46.9)
 III+IV 479 (48.8) 143 (43.5) 104 (46.4) 232 (54.1)
Length of stay (days) 19.6±10.1 20.1±9.1 18.8±9.5 19.8±11.1
Time to surgery (days) 1.3±1.7 1.4±2.0 1.2±1.8 1.2±1.4
In-hospital mortality 16 (1.6) 4 (1.2) 5 (2.2) 7 (1.6)
Mortality at 6 months 55 (5.6) 17 (5.2) 9 (4.0) 29 (6.8)
Perioperative complications 273 (27.8) 94 (28.6) 47 (21.0) 132 (30.8)
Categorical data are presented as n (%) and continuous data are presented as the mean±standard deviation.
ASA-PS, American Society of Anesthesiologists physical status; HCM, hospitalist consultant model; HM, hospitalist model; OM, conventional orthopaedic surgeon–led care.

The number of study subjects was similar between months of the year (Table 2). The mean total medical costs during a hospital stay were higher in the HM group (JPY 1,611,489 [AUD 16,114; JPY 100=AUD 1]) than in the OM (JPY 1,457,602 [AUD 14,576]) and HCM (JPY 1,466,977 [AUD 14,669]) groups.

Table 2. Number of study subjects according to time of year
  All (n=982) OM (n=329) HCM (n=224) HM (n=429)
January 94 (9.6) 27 (8.2) 25 (11.2) 42 (9.8)
February 88 (9.0) 28 (8.5) 21 (9.4) 39 (9.1)
March 88 (9.0) 35 (10.6) 20 (8.9) 33 (7.7)
April 80 (8.1) 24 (7.3) 19 (8.5) 37 (8.6)
May 74 (7.5) 30 (9.1) 14 (6.3) 30 (7.0)
June 74 (7.5) 30 (9.1) 15 (6.7) 29 (6.8)
July 72 (7.3) 21 (6.4) 21 (9.4) 30 (7.0)
August 78 (7.9) 31 (9.4) 13 (5.8) 34 (7.9)
September 67 (6.8) 24 (7.3) 19 (8.5) 24 (6.8)
October 70 (7.1) 18 (5.5) 20 (8.9) 32 (7.1)
November 85 (8.7) 27 (8.2) 15 (6.7) 43 (8.7)
December 112 (11.4) 34 (10.3) 22 (9.8) 56 (11.4)
All data are categorical and are presented as n (%).
HCM, hospitalist consultant model; HM, hospitalist model; OM, conventional orthopaedic surgeon–led care.

In adjusted analysis by age, gender, fracture type, month and ASA-PS, patients managed with the HCM were more likely to have a shorter length of stay (log [length of stay] coefficient –0.09; 95% confidence interval [CI]: –0.16 to –0.02; P=0.015) and to have fewer perioperative complications (OR 0.63; 95% CI: 0.41 to 0.96; P=0.03). Patients managed within the HM were more likely to have a shorter time to surgery (coefficient –0.27; 95% CI: –0.52 to –0.03; P=0.028; Table 3). Common complications were deep vein thrombosis in the OM group and aspiration pneumonia in the HCM group. Myocardial injury after non-cardiac surgery (MINS) was detected only in the HM group (Table 4). There were six cases of COVID-19 (1.4%) in the HM group, but there were no deaths and no impact on the surgical waiting period.

Table 3. Differences in outcomes using conventional orthopaedic surgeon-led care as the reference group
  HCM HM
Coefficient (95% CI) P value Coefficient (95% CI) P value
Log (Length of stay) –0.09 (–0.16, –0.02) 0.015* –0.05 (–0.11, 0.01) 0.078
Time to surgery –0.20 (–0.48, 0.09) 0.18 –0.27 (–0.52, –0.03) 0.028
  OR (95% CI) P value OR (95% CI) P value
In-hospital mortality 1.59 (0.44–6.00) 0.48 1.10 (0.35–3.87) 0.87
6-month mortality 0.79 (0.32–1.83) 0.59 1.22 (0.65–2.36) 0.54
Perioperative complication 0.63 (0.41–0.96) 0.03** 1.00 (0.72–1.40) 0.99
Covariates were age, gender, fracture type, month and American Society of Anesthesiologists physical status (1: I+II; 0, III+IV).
*Multiple regression analysis was used for selected coefficients with a P value <0.2 in a univariate analysis.
**Logistic regression analysis was used for selected covariates with a P value <0.2 in a univariate analysis.
CI, confidence interval; HCM, hospitalist consultant model; HM, hospitalist model; OR, odds ratio.
 
 
Table 4. Common complications
  All (n=982) OM (n=329) HCM (n=224) HM (n=429)
DVT 60 (6.1) 22 (6.7) 4 (1.8) 34 (7.9)
MINS 56 (5.7) n/a n/a 56 (13.1)
Pyelonephritis 39 (4.0) 19 (5.8) 4 (1.8) 16 (3.7)
Aspiration pneumonia 31 (3.2) 8 (2.4) 10 (4.5) 13 (3.0)
Heart failure 26 (2.6) 11 (3.3) 6 (2.7) 9 (2.1)
Haemorrhagic shock 19 (1.9) 7 (2.1) 4 (2.8) 8 (1.9)
Acute kidney injury 18 (1.8) 7 (2.1) 5 (2.2) 6 (1.4)
Atrial fibrillation 11 (1.1) 5 (1.5) 2 (0.9) 4 (0.9)
Delirium 11 (1.1) 3 (0.9) 2 (0.9) 6 (1.4)
Bacteraemia 10 (1.0) 5 (1.5) 2 (0.9) 3 (0.7)
Data are presented as n (%).
DVT, deep vein thrombosis; HCM, hospitalist consultant model; HM, hospitalist model; MINS, myocardial injury after non-cardiac surgery; n/a, not applicable; OM, conventional orthopaedic surgeon–led care.

Discussion

Summary of main findings

In this retrospective cohort study, time to surgery was shorter if patients were managed within the HM. No impact on morbidity was found. Length of stay was shorter and the rate of complications was lower if patients were managed within the HCM. To the best of our knowledge, this study is the first to investigate the impact of these hospitalist intervention methods on morbidity in patients with hip fractures in a real-world clinical context. Our findings highlight the value of structured management of hip fractures by an HM system.

Differences between studies and strengths of the present study

The time to surgery was shorter in the HM than OM group (1.2 vs 1.4 days). Clinical practice guidelines recommend surgery within 24–48 hours of injury, unless a delay is required to stabilise comorbidities, because early surgical management improves pain control, shortens hospital stays and lowers complications.23,24 Multidisciplinary care, perioperative evaluations and management of clinical conditions by a hospitalist team including board-certified family physicians, regular hip fracture conferences and the use of a flagging and risk stratification algorithm system might contribute to the shortening of the time to surgery. Importantly, the HM system was shown to be associated with a reduction in the time to surgery without an adverse effect on rates of complications or death.

Compared with conventional care, perioperative medical care provided by hospitalists is associated with significant reductions in time to surgery and length of stay, with no differences in mortality.3,5 Our findings support previous results that decreased time to surgery was not associated with an observable effect on mortality. The time to surgery in each of the three groups (OM, HCM, HM) in our analysis was considerably lower than the 48-hour limit, implying that operating within the normally recognised 48-hour time range might have no effect on mortality.

Shorter time to surgery reportedly reduces complications,25 but we observed no difference in the rate of complications between groups, despite a shorter time to surgery in our HM group. In our study, the complication rate was 30.8% and the in-hospital mortality rate was 1.6% in the HM group, which are lower than the rates in previous reports of HM.5,26 This might dull the effect of HM on these outcomes. A landmark historical cohort study of a hospitalist model that included similarly elderly patients (mean age 83 years) with hip fractures had a reported complication rate of 16.1% with major complications, 74.3% with intermediate complications and 27% with minor complications, and in-hospital mortality was 4.4%.5 Another retrospective cohort study of a hospitalist model that included elderly patients (mean age 82 years) with hip fractures had a reported complication rate of 42% for major complications, 36% for intermediate complications and 79% for minor complications, and the rate of in-hospital mortality was reported to be 12%.26 Common complications seen in the landmark historical cohort study were urinary tract infection (20.4% of patients treated by hospitalists and 17.0% of patients who received non-hospitalist treatment), delirium (17.8% and 32.2%, respectively), and pneumonia (14.4% and 12.3%, respectively).5 Almost two decades have passed since that study, but it is noteworthy that only 3.0%, 1.4% and 3.7% of patients in the HM group in the present study developed aspiration pneumonia, delirium and pyelonephritis, respectively.

There is another explanation for the similar rate of complications between the groups in our study. MINS was detected only in the HM group when we performed surveillance of MINS with the HFT. The improved detection of complications including MINS might have influenced the similar rate of complications between groups, despite the lesser influence of the orthopaedic team.

Clinical implications

The present study might have pragmatic implications for the care of patients with hip fractures by hospitalists including family physicians, especially applicable to community hospitals in primary care settings. A certain proportion of family physicians practise in community hospitals.27–29 Family physicians offer a wide range of holistic medical services, such as acute and chronic care, hospice and palliative care and preventative medicine.30 Medical teams comprised of family physicians are thought to be useful for hip fracture care with consideration of multimorbidity and polypharmacy. Further studies are needed to investigate whether a family physician–led hospitalist model could reduce morbidity and mortality regarding the management of patients with hip fractures.

Total costs during hospital stays were higher in the HM group, partly due to the increase in the Diagnosis Procedure Combination institutional coefficient for costs during hospital stays from April 2020 in our hospital (Akashi Medical Centre). The higher number of patients requiring bipolar hip arthroplasty also contributed to the increase in the costs in the HM group (46.2%) compared with those for patients in the OM group (32.8%) and the HCM group (32.1%), because bipolar hip arthroplasty (JPY 195,000 [AUD 1950]) is a slightly more expensive treatment than an intramedullary nail (JPY 188,100 [AUD 1881]).

Limitations

Our study has several limitations. First, data were collected from a single institution only, but we suggest that our results are representative of primary care settings. A second limitation is that the data were collected retrospectively, and prospective validation of results in a multicentre study is needed. Third, group allocation was not randomised, so our results might have been partially affected by confounding factors. Nevertheless, the characteristics of the study subjects were similar between the groups. To overcome these limitations, we propose the need for double-blind randomised studies to eliminate confounding variables. Finally, our results might have been skewed by the timing, because some of the study period coincided with the COVID-19 pandemic.

Conclusion

Our results suggest that a family physician–led hospitalist model facilitates earlier surgery for hip fractures than a conventional care model. Reducing surgical waiting times might improve patient experiences and facilitate hospital management. Morbidity was not affected by the family physician–led hospitalist model in our study.

Competing interests: None.
Provenance and peer review: Not commissioned, externally peer reviewed.
Funding: None.
Correspondence to:
maru-tkb@umin.ac.jp
Acknowledgements
The authors thank Benjamin Phillis of Akashi Medical Center for proofreading and editing the manuscript.
This event attracts CPD points and can be self recorded

Did you know you can now log your CPD with a click of a button?

Create Quick log
References
  1. Grigoryan KV, Javedan H, Rudolph JL. Orthogeriatric care models and outcomes in hip fracture patients: A systematic review and meta-analysis. J Orthop Trauma 2014;28(3):e49–55. doi: 10.1097/BOT.0b013e3182a5a045. Search PubMed
  2. Prestmo A, Hagen G, Sletvold O, et al. Comprehensive geriatric care for patients with hip fractures: A prospective, randomised, controlled trial. Lancet 2015;385(9978):1623–33. doi: 10.1016/S0140-6736(14)62409-0. Search PubMed
  3. Roy A, Heckman MG, Roy V. Associations between the hospitalist model of care and quality-of-care-related outcomes in patients undergoing hip fracture surgery. Mayo Clin Proc 2006;81(1):28–31. doi: 10.4065/81.1.28. Search PubMed
  4. Bub C, Stapleton E, Iturriaga C, et al. Implementation of a geriatrics-focused orthopaedic and hospitalist fracture program decreases perioperative complications and improves resource utilization. J Orthop Trauma 2022;36(4):213–17. doi: 10.1097/BOT.0000000000002258. Search PubMed
  5. Phy MP, Vanness DJ, Melton LJ 3rd, et al. Effects of a hospitalist model on elderly patients with hip fracture. Arch Intern Med 2005;165(7):796–801. doi: 10.1001/archinte.165.7.796. Search PubMed
  6. Batsis JA, Phy MP, Melton LJ III, et al. Effects of a hospitalist care model on mortality of elderly patients with hip fractures. J Hosp Med 2007;2(4):219–25. doi: 10.1002/jhm.207. Search PubMed
  7. Rohatgi N, Weng Y, Kittle J, Ahuja N. Merits of surgical comanagement of patients with hip fracture by dedicated orthopaedic hospitalists. J Am Acad Orthop Surg Glob Res Rev 2021;5(3):e20.00231. doi: 10.5435/JAAOSGlobal-D-20-00231. Search PubMed
  8. Stephens JR, Chang JW, Liles EA, Adem M, Moore C. Impact of hospitalist vs. non-hospitalist services on length of stay and 30-day readmission rate in hip fracture patients. Hosp Pract (1995) 2019;47(1):24–27. Search PubMed
  9. Shigemoto K, Sawaguchi T, Horii T, et al. Multidisciplinary care model for geriatric patients with hip fracture in Japan: 5-year experience. Arch Orthop Trauma Surg 2022;142(9):2205–14. doi: 10.1007/s00402-021-03933-w. Search PubMed
  10. Tsunemitsu A, Tsutsumi T, Inokuma S, Imanaka Y. Effects of hospitalist co-management for hip fractures. J Orthop Sci 2024;29(1):278–85. doi: 10.1016/j.jos.2022.11.004. Search PubMed
  11. Mendelson DA, Friedman SM. Principles of comanagement and the geriatric fracture center. Clin Geriatr Med 2014;30(2):183–89. doi: 10.1016/j.cger.2014.01.016. Search PubMed
  12. Rao SS, Cherukuri M. Management of hip fracture: The family physician’s role. Am Fam Physician 2006;73(12):2195–200. Search PubMed
  13. Schroeder JD, Turner SP, Buck E. Hip fractures: Diagnosis and management. Am Fam Physician 2022;106(6):675–83. Search PubMed
  14. Seto H, Ishimaru N, Ohnishi J, et al. Multidisciplinary team deprescribing intervention for polypharmacy in elderly orthopedic inpatients: A propensity score-matched analysis of a retrospective cohort study. Intern Med 2022;61(16):2417–26. doi: 10.2169/internalmedicine.8929-21. Search PubMed
  15. Ishimaru N, Waki T, Shimokawa T, et al. Impact of flagging/risk stratification system on complications in hospitalist hip fracture co-management: Retrospective cohort study. Indian J Orthop 2024;58(4):371–78. doi: 10.1007/s43465-024-01112-8. Search PubMed
  16. Boynton PM, Greenhalgh T. Selecting, designing, and developing your questionnaire. BMJ 2004;328(7451):1312–15. doi: 10.1136/bmj.328.7451.1312. Search PubMed
  17. Bhandari M, Swiontkowski M. Management of acute hip fracture. N Engl J Med 2017;377(21):2053–62. doi: 10.1056/NEJMcp1611090. Search PubMed
  18. Duceppe E, Parlow J, MacDonald P, et al. Canadian Cardiovascular Society Guidelines on perioperative cardiac risk assessment and management for patients who undergo noncardiac surgery. Can J Cardiol 2017;33(1):17–32. doi: 10.1016/j.cjca.2016.09.008. Search PubMed
  19. Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group. KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease–mineral and bone disorder (CKD-MBD). Kidney Int Suppl (2011) 2017;7(1):1–59. Search PubMed
  20. Brox WT, Roberts KC, Taksali S, et al. The American Academy of Orthopaedic Surgeons evidence-based guideline on management of hip fractures in the elderly. J Bone Joint Surg Am 2015;97(14):1196–99. doi: 10.2106/JBJS.O.00229. Search PubMed
  21. Dahl C, Madsen C, Omsland TK, et al. The association of cold ambient temperature with fracture risk and mortality: National data from Norway – a Norwegian Epidemiologic Osteoporosis Studies (NOREPOS) study. J Bone Miner Res 2022;37(8):1527–36. doi: 10.1002/jbmr.4628. Search PubMed
  22. Modarres R, Ouarda TB, Vanasse A, Orzanco MG, Gosselin P. Modeling seasonal variation of hip fracture in Montreal, Canada. Bone 2012;50(4):909–16. doi: 10.1016/j.bone.2012.01.004. Search PubMed
  23. O’Connor MI, Switzer JA. AAOS clinical practice guideline summary: Management of hip fractures in older adults. J Am Acad Orthop Surg 2022;30(20):e1291–96. doi: 10.5435/JAAOS-D-22-00125. Search PubMed
  24. Griffiths R, Babu S, Dixon P, et al. Guideline for the management of hip fractures 2020: Guideline by the Association of Anaesthetists. Anaesthesia 2021;76(2):225–37. doi: 10.1111/anae.15291. Search PubMed
  25. Orosz GM, Magaziner J, Hannan EL, et al. Association of timing of surgery for hip fracture and patient outcomes. JAMA 2004;291(14):1738–43. doi: 10.1001/jama.291.14.1738. Search PubMed
  26. Chuang CH, Pinkowsky GJ, Hollenbeak CS, Armstrong AD. Medicine versus orthopaedic service for hospital management of hip fractures. Clin Orthop Relat Res 2010;468(8):2218–23. doi: 10.1007/s11999-010-1290-z. Search PubMed
  27. Chavey WE, Medvedev S, Hohmann S, Ewigman B. The status of adult inpatient care by family physicians at US academic medical centers and affiliated teaching hospitals 2003 to 2012: The impact of the hospitalist movement. Fam Med 2014;46(2):94–99. Search PubMed
  28. Neimanis I, Woods A, Zizzo A, et al. Role of family physicians in an urban hospital: Tracking changes between 1977, 1997, and 2014. Can Fam Physician 2017;63(3):221–27. Search PubMed
  29. Wang YH, Li HC, Liao KY, Chen TJ, Hwang SJ. Family physicians working at hospitals: A 20-year nationwide trend analysis in Taiwan. Int J Environ Res Public Health 2021;18(17):9097. doi: 10.3390/ijerph18179097. Search PubMed
  30. Phillips WR, Haynes DG. The domain of family practice: Scope, role, and function. Fam Med 2001;33(4):273–77. Search PubMed

General practiceHealth systemsHip fractureOrthopaedics

Download article